These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 165666)

  • 21. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of an activator of multiple forms of cyclic nucleotides phosphodiesterase of rat cerebrum by isoelectric focusing.
    Pledger WJ; Thompson WJ; Strada SJ
    Biochim Biophys Acta; 1975 Jun; 391(2):334-40. PubMed ID: 167832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca-2+/Mg-2+-dependent cyclic nucleotide phosphodiesterase and its activator protein.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Adv Cyclic Nucleotide Res; 1975; 5():163-78. PubMed ID: 165664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cyclic nucleotide phosphodiesterase.
    Appleman MM; Terasaki WL
    Adv Cyclic Nucleotide Res; 1975; 5():153-62. PubMed ID: 165663
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
    Kelly JJ; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple forms of cyclic nucleotide phosphodiesterase in pig epidermis.
    Adachi K; Levine V; Halprin KM; Iizuka H; Yoshikawa K
    Biochim Biophys Acta; 1976 Apr; 429(2):498-507. PubMed ID: 4133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A neurobiological role for a protein activator of cyclic nucleotide phosphodiesterase.
    Uzunov P; Gnegy M; Lehne R; Revuelta A; Costa E
    Adv Biochem Psychopharmacol; 1976; 15():283-301. PubMed ID: 15421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ontogenic development of a phosphodiesterase activator and the multiple forms of cyclic AMP phosphodiesterase of rat brain.
    Strada SJ; Uzunov P; Weiss B
    J Neurochem; 1974 Dec; 23(6):1097-103. PubMed ID: 4375704
    [No Abstract]   [Full Text] [Related]  

  • 29. Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.
    Hidaka H; Asano T
    J Biol Chem; 1976 Dec; 251(23):7508-16. PubMed ID: 187590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bovine heart protein activator of cyclic nucleotide phosphodiesterase.
    Wang JH; Teo TS; Ho HC; Stevens FC
    Adv Cyclic Nucleotide Res; 1975; 5():179-94. PubMed ID: 165665
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
    Sugden MC; Ashcroft SJ
    Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic nucleotide phosphodiesterase in silkworm. Separation and characterization of multiple forms of the enzyme.
    Morishima I
    Biochim Biophys Acta; 1975 May; 391(1):75-83. PubMed ID: 237560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic nucleotide phosphodiesterase from a particulate fraction of rat brain. Evidence for an activator deficient form.
    Lindl T; Chapman G
    Biochem Biophys Res Commun; 1976 Aug; 71(4):1273-82. PubMed ID: 9937
    [No Abstract]   [Full Text] [Related]  

  • 35. Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3':5'-cyclic monophosphate.
    Arch JR; Newsholme EA
    Biochem J; 1976 Sep; 158(3):603-22. PubMed ID: 186042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
    Hait WN; Weiss B
    Biochim Biophys Acta; 1977 Mar; 497(1):86-100. PubMed ID: 14711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cylic nucleotide phosphodiesterase in silkworm. Characterization of cyclic GMP phosphodiesterase.
    Morishima I
    Biochim Biophys Acta; 1975 Dec; 410(2):310-7. PubMed ID: 1092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents.
    Weiss B; Hait WN
    Annu Rev Pharmacol Toxicol; 1977; 17():441-77. PubMed ID: 17360
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes.
    Thompson WJ; Ross CP; Pledger WJ; Strada SJ; Banner RL; Hersh EM
    J Biol Chem; 1976 Aug; 251(16):4922-9. PubMed ID: 182685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of multiple forms of cyclic nucleotide phosphodiesterase from liver.
    Terasaki WL; Russell TR; Appleman MM
    Methods Enzymol; 1974; 38():257-9. PubMed ID: 4375757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.